A newly developed combination for respiratory tract infections (RTIs), featuring a clinically proven, distinct, and synergistic mechanism of action. The active ingredients possess antiviral, antibacterial, immunomodulatory, and anti-inflammatory properties, while also significantly increasing the ciliary beat frequency (CBF) in the respiratory tract. Additionally, they offer a superior antioxidant effect.
A newly developed combination for complex respiratory conditions such as asthma, COPD, and cystic fibrosis, featuring clinically proven mucolytic, anti-inflammatory, and antibiotic-potentiating properties, along with powerful antioxidant effects. Clinical trials have demonstrated that the ingredients significantly diminish SARS-CoV-2 infection, in addition to offering numerous other therapeutic benefits, all of which are well-documented in clinical studies.
